Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GETI-B.STthis companyGetinge AB (publ)	SEK 275.80	26.39×	2.03×	1.7×	11.11×	-23.6%	44.5%	13.1%	6.5%	7.7%	7.3%	4.4%	0.37×	1.24×	8.86×	1.32×	2.1%	5	3.09	3	B
ARCOMA.STArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
SEDANA.STSedana Medical AB (publ)	SEK 9.64	-17.13×	1.13×	5.1×	-92.41×	-488.3%	71.3%	-16.1%	-29.6%	-6.6%	-3.5%	-7.4%	0.01×	8.53×	-22.12×	3.4×	0.0%	2	10.28	2	C+
XVIVO.STXvivo Perfusion AB (publ)	SEK 200.80	233.25×	2.78×	7.24×	37.29×	-172.4%	65.7%	11.5%	3.1%	1.2%	2.7%	-2.6%	0.06×	-1.09×	2.1×	5.77×	0.0%	6	12.47	3	B-
Peer median	—	20.97×	1.41×	5.1×	4.36×	-172.4%	65.7%	6.6%	3.1%	1.2%	2.7%	-2.6%	0.01×	-1.09×	2.1×	3.49×	0.0%	6	10.28	3	—